PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Ibandronate Sodium ×

UPDATED
Regulatorische Updates
4. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA078948 for Ibandronate Sodium Tablet
The FDA has approved ANDA078948 for a prescription oral tablet of Ibandronate Sodium 150 mg, sponsored by Apotex and manufactured by Golden State Medical Supply.